4-Phenylbutyric acid suppresses inflammation through regulation of endoplasmic reticulum stress of endothelial cells stimulated by uremic serum

Life Sciences

Volumn 103, Issue 1, 2014, Pages 15-24

  Zeng, Wei ^a   Guo, Yan Hong ^a   Qi, Wei ^a   Chen, Ji Gang ^a   Yang, Li Ling ^a   Luo, Zhi Feng ^a   Mu, Jiao ^a   Feng, Bing ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

4 Phenylbutyric acid; Atherosclerosis; Chronic renal failure; Endoplasmic reticulum stress; Inflammatory activation

Indexed keywords

4 PHENYLBUTYRIC ACID; GLUCOSE REGULATED PROTEIN 78; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PYRROLIDINE DITHIOCARBAMATE; VASCULOTROPIN;

ADULT; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; MALE; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; UREMIA;

4-PHENYLBUTYRIC ACID; ATHEROSCLEROSIS; CHRONIC RENAL FAILURE; ENDOPLASMIC RETICULUM STRESS; INFLAMMATORY ACTIVATION;

CELL PROLIFERATION; CHEMOKINE CCL2; CULTURE MEDIA; ENDOPLASMIC RETICULUM STRESS; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; NF-KAPPA B; PHENYLBUTYRATES; UREMIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899482885     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2014.03.007     Document Type: Article

References (40)

1. N. Amabile, A.P. Guerin, A. Leroyer, Z. Mallat, C. Mquyen, and J. Boddaert Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure J Am Soc Nephrol 16 2005 3381 3388 (Pubitemid 46179341)
2. K. Amann, and E. Ritz Microvascular disease - the cinderella of uraemic heart disease Nephrol Dial Transplant 15 2000 1493 1503
3. R.C. Austin The unfolded protein response in health and disease Antioxid Redox Signal 11 2009 2279 2287
4. M. Baggiolini, B. Dewald, and B. Moser Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines Adv Immunol 55 1994 97 179
5. B. Barleon, S. Sozzani, D. Zhou, H.A. Weich, A. Mantovani, and D. Marmé Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1 Blood 87 1996 3336 3343 (Pubitemid 26115364)
6. J. Blacher, M.E. Safar, B. Pannier, A.P. Guerin, S.J. Marchais, and G.M. London Prognostic significance of arterial stiffness measurements in end-stage renal disease patients Curr Opin Nephrol Hypertens 11 2002 629 634 (Pubitemid 35440845)
7. A.G. Bostom, and L. Lathrop Hyperhomocysteinemia in end stage renal disease: prevalence etiology and potential relationship to atherosclerotic outcome Kidney Int 52 1997 10 20
8. S. Bro, A. Flyvbjerg, C.J. Binder, C.A. Bang, L. Denner, and K. Olgaard et al. A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice Atherosclerosis 201 2008 274 280
9. G.S. Di Marco, M. Hausberg, U. Hillebrand, P. Rustemeyer, W. Wittkowski, and D. Lang et al. Increased inorganic phosphate induces human endothelial cell apoptosis in vitro Am J Physiol Renal Physiol 294 2008 F1381 F1387
10. J.G. Dickhout, G.S. Hossain, L.M. Poxxa, J. Zhou, S. Lhtoak, and R.C. Austin Peroxynitrite causes endoplasmic reticulum stress and apoptosis in human vascular endothelium: implications in atherogenesis Arterioscler Thromb Vasc Biol 25 2005 2623 2629 (Pubitemid 43732288)
11. B. Feng, Y. Zhang, J. Mu, Z. Ye, W. Zeng, and W. Qi et al. Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia J Cardiovasc Pharmacol 55 2010 129 138
12. B. Feng, Y.Q. Zhang, J. Mu, F.H. Yuan, Z.L. Ye, and W. Qi et al. Uraemic serum induces dysfunction of vascular endothelial cells: role of ubiquitin-proteasome pathway Exp Physiol 96 2011 801 815
13. A. Fornoni, A. Ijaz, T. Tejada, and O. Lenz Role of inflammation in diabetic nephropathy Curr Diabetes Rev 4 2008 10 17 (Pubitemid 351216880)
14. N. Futrakul, P. Butthep, and P. Futrakul Altered vascular homeostasis in chronic kidney disease Clin Hemorheol Microcirc 38 2008 201 207 (Pubitemid 351185407)
15. Z.J. Guo, H.X. Niu, F.F. Hou, L. Zhang, N. Fu, and R. Naqai et al. Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway Antioxid Redox Signal 10 2008 1699 1712
16. P. Haberzettl, E. Vladykovskaya, S. Srivastava, and A. Bhatnagar Role of endoplasmic reticulum stress in acrolein-induced endothelial activation Toxicol Appl Pharmacol 234 2009 14 24
17. J.R. Horowitz, A. Rivard, R. van der Zee, M. Hariawala, D.D. Sheriff, and D.D. Esakof et al. Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Evidence for a maintenance role in quiescent adult endothelium Arterioscler Thromb Vasc Biol 17 1997 2793 2800 (Pubitemid 28016023)
18. G.S. Hotamisligil Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 2010 900 917
19. R.J. Kaufman Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls Genes Dev 13 1999 1211 1233 (Pubitemid 29250189)
20. R.J. Kaufman Orchestrating the unfolded protein response in health and disease J Clin Invest 110 2002 1389 1398 (Pubitemid 35396907)
21. M. Kitamura Endoplasmic reticulum stress and unfolded protein response in renal pathophysiology: Janus faces Am J Physiol Renal Physiol 295 2008 323 334
22. A.S. Lee The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress Methods 35 2005 373 381 (Pubitemid 40445371)
23. D.W. Leung, G. Cachianes, W.J. Kuang, D.V. Goeddel, and N. Ferrara Vascular endothelial growth factor is a secreted angiogenic mitogen Science 246 1989 1306 1309 (Pubitemid 20066716)
24. H.P. Lin, S.K. Kulp, P.H. Tseng, C.C. Yang, C.S. Chen, and C.S. Chen Growth inhibitory effects of celecoxib in human unbilical vein endothelial cells are mediated through G1 arrest via multiple signaling mechanisms Mol Cancer Ther 3 2004 1671 1680 (Pubitemid 40136723)
25. Y. Liu, H. Yang, K. Otaka, H. Takatsuki, and A. Sakanishi Effects of vascular endothelial growth factor (VEGF) and chondroitin sulfate A on human monocytic THP-1 cell migration Colloids Surf B Biointerfaces 43 2005 216 220 (Pubitemid 40909845)
26. S.T. Morris, J.J. McMurray, R.S. Rodger, and A.G. Jardine Impaired endothelium-dependent vasodilatation in uraemia Nephrol Dial Transplant 15 2000 1194 2000
27. J.J. Oppenheim, C.O.C. Zachariae, N. Mukaida, and K. Matsushima Properties of the novel proinflammatory superantigen "intercrine" cytokine family Annu Rev Immunol 9 1991 617 648
28. K. Pawlak, S. Brzosko, M. Mysliwiec, and D. Pawlak Kynurenine, quinolinic acid - the new factors linked to carotid atherosclerosis in patients with end-stage renal disease Atherosclerosis 204 2009 561 566
29. V.I. Rasheva, and P.M. Domingos Cellular responses to endoplasmic reticulum stress and apoptosis Apoptosis 14 2009 996 1007
30. Y. Sekine, K. Takeda, and H. Ichijo The ASK1-MAP kinase signaling in ER stress and neurodegenerative diseases Curr Mol Med 6 2006 87 97
31. D.R. Senger, L.F. Brown, K.P. Claffey, and H.F. Dvorak Vascular permeability factor, tumor angiogenesis and stroma generation Invasion Metastasis 14 1994 385 394
32. A.V. Sima, C.S. Stancu, and M. Simionescu Vascular endothelium in atherosclerosis Cell Tissue Res 335 2009 191 203
33. F. Stam, C. van Guldener, A. Becker, J.M. Dekker, R.J. Heine, and L.M. Bouter et al. Endothelial dysfunction contributes to renal function associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study J Am Soc Nephrol 17 2006 537 545
34. G.H. Tesch MCP-1/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy Am J Physiol Renal Physiol 294 2008 F697 F701
35. M. Tonelli, N. Wiebe, B. Culleton, A. House, C. Rabbat, and M. Fok et al. Chronic kidney disease and mortality risk: a systematic review J Am Soc Nephrol 17 2006 2034 2047 (Pubitemid 44036188)
36. L. Trevisi, I. Pighin, S. Bazzan, and S. Luciani Inhibition of 3-(4,5-dimethylthiazol-2-yl)-2,3-diphenyltertazolium bromide (MTT) endocytosis by ouabain in human endothelial cells 2006
37. F. Urano, X. Wang, A. Bertolotti, Y. Zhang, P. Chung, and H.P. Harding et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1 Science 287 2000 664 666 (Pubitemid 30070916)
38. H. Yamazaki, N. Hiramatsu, K. Hayakawa, Y. Tagawa, M. Okamura, and R. Ogata et al. Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response J Immunol 183 2009 1480 1487
39. K.Z. Zhang, and R.J. Kaufman From endoplasmic-reticulum stress to the inflammatory response Nature 454 2008 455 462
40. C. Zhu, Z.J. Xiong, X.H. Chen, Z.Q. Lu, G.Y. Zhou, and D.J. Wang et al. Soluble vascular endothelial growth factor (VEGF) receptor-1 inhibits migration of human monocytic THP-1 cells in response to VEGF Inflamm Res 60 2011 769 774